Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction
- PMID: 36694856
- PMCID: PMC9858885
- DOI: 10.7759/cureus.33988
Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction
Abstract
Thyrotoxicosis-induced dilated cardiomyopathy is a rare but potentially life-threatening complication of thyrotoxicosis, with an incidence of <1%. This condition is characterized by a dilatation of the ventricular chamber and a decrease in cardiac contractility. Untreated, it can lead to irreversible changes in cardiac structure and function, including dilated ventricular chamber, a decrease in ejection fraction (EF), and an increased risk of atrial fibrillation. We present a case of a 39-year-old patient with a diagnosis of thyrotoxicosis-induced acute heart failure. A two-dimensional (2D) echocardiogram disclosed an ejection fraction of 36%, with diffuse mild dilation of the atria and ventricles with trace mitral and tricuspid regurgitation. The anti-thyroid-stimulating hormone (TSH) receptor was positive, and Grave's disease was diagnosed. The patient eventually returned to baseline functional status and could return to basic activities of daily living without limitations. The patient was encouraged to follow up with outpatient cardiology. Early diagnosis of cardiac involvement in patients with thyrotoxicosis is critical. Promptly delivered intensive treatment with the rapid achievement of euthyroid state can potentially reverse cardiac dysfunction and improve patient outcomes.
Keywords: congestive heart failure; dilated cardiomyopathy; hyperthyroidism; systolic dysfunction; thyrotoxicosis.
Copyright © 2023, Khalil et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Thyrotoxic Cardiomyopathy Unveiled: Insights From a Compelling Case Report.Cureus. 2023 Dec 27;15(12):e51172. doi: 10.7759/cureus.51172. eCollection 2023 Dec. Cureus. 2023. PMID: 38283537 Free PMC article.
-
Thyrotoxicosis-Induced Cardiomyopathy Complicated by Refractory Cardiogenic Shock Rescued by Extracorporeal Membrane Oxygenation.Am J Case Rep. 2022 Jan 25;23:e935029. doi: 10.12659/AJCR.935029. Am J Case Rep. 2022. PMID: 35075099 Free PMC article.
-
Significant reversal of thyrotoxicosis-associated dilated cardiomyopathy with induction of the euthyroid state.J Endocrinol Invest. 1996 Jan;19(1):54-8. doi: 10.1007/BF03347859. J Endocrinol Invest. 1996. PMID: 8851693
-
Thyrotoxic cardiac disease.Curr Heart Fail Rep. 2008 Sep;5(3):170-6. doi: 10.1007/s11897-008-0026-9. Curr Heart Fail Rep. 2008. PMID: 18752767 Review.
-
European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):919-48. doi: 10.1093/ehjci/jev139. Epub 2015 Jul 2. Eur Heart J Cardiovasc Imaging. 2015. PMID: 26139361 Review.
Cited by
-
Thyrotoxic Cardiomyopathy Unveiled: Insights From a Compelling Case Report.Cureus. 2023 Dec 27;15(12):e51172. doi: 10.7759/cureus.51172. eCollection 2023 Dec. Cureus. 2023. PMID: 38283537 Free PMC article.
-
Reversible acute heart failure induced by thyrotoxic cardiomyopathy: A case report.Medicine (Baltimore). 2024 May 24;103(21):e38305. doi: 10.1097/MD.0000000000038305. Medicine (Baltimore). 2024. PMID: 38788008 Free PMC article.
-
Unusual Presentations of Thyrotoxic Tricuspid and Mitral Regurgitations in 62 Adults: A Systematic Review of Case Reports with In-depth Pathophysiological Review.Eur Cardiol. 2024 Jul 29;19:e13. doi: 10.15420/ecr.2024.05. eCollection 2024. Eur Cardiol. 2024. PMID: 39144378 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources